Development of novel-nanobody-based lateral-flow immunochromatographic strip test for rapid detection of recombinant human interferon α2b

• Main Authors: Xi Qin (Author), Maoqin Duan (Author), Dening Pei (Author), Jian Lin (Author), Lan Wang (Author), Peng Zhou (Author), Wenrong Yao (Author), Ying Guo (Author), Xiang Li (Author), Lei Tao (Author), Youxue Ding (Author), Lan Liu (Author), Yong Zhou (Author), Chuncui Jia (Author), Chunming Rao (Author), Junzhi Wang (Author)
• Format: Book
• Published: Elsevier, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Recombinant human interferon α2b (rhIFNα2b) is widely used as an antiviral therapy agent for the treatment of hepatitis B and hepatitis C. The current identification test for rhIFNα2b is complex. In this study, an anti-rhIFNα2b nanobody was discovered and used for the development of a rapid lateral...